Health

  Biopharma companies may want to pause before they plow ahead with their next acquisition. The costs are rising and...

As inflation soars and pandemic-era aid comes to an end, many industries and Americans have been struggling to thrive in...

  Sanofi multiple sclerosis drug candidate tolebrutinib boasts a key feature: the ability to reach into brain and spinal cord...

As Pride Month comes to a close, it is important to remember that members of the LGBTQ community still experience...

The issues of choice and motherhood have dominated headlines over the past week. This discourse has centered around a woman’s...

  The federal government has reached a deal to pay $3.2 billion to secure a new supply of the Pfizer/BioNTech...

A recent webinar by Medable discussed steps it’s taking to improve clinical trial design through decentralized clinical trials (DCT). The...

The highly fragmented nature of the home care sector often results in delayed access and frustration for seniors hoping to...

“Technology is only as good as the impact it has on both patients and clinicians,” said Chris Altchek, founder and...

  ReCode Therapeutics was formed around new science potentially enabling delivery of genetic medicines to various organs in the body,...